Article

Blood, Lung Cancer Drug Approvals Highlight AJPB Week in Review

Author(s):

AJPB staff

Top articles of the week from The American Journal of Pharmacy Benefits.

Related Videos
Patient receiving diabetes consultation -- Image credit: Syda Productions | stock.adobe.com
Related Content
Malignant tumors on a brain | Image Credit: © Nima - stock.adobe.com
February 4th 2025

Central Nervous System Disease Drives Mortality in HER2+ Metastatic Breast Cancer Despite Longer Survival

Alexandra Gerlach, Associate Editor
The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma
January 31st 2025

The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma

Alexandra Gerlach, Associate Editor
World Cancer Day: A Call to Action
February 4th 2025

World Cancer Day: A Call to Action

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
Exploring Precision Medicine and PGx: Sara Rogers, PharmD, Previews Precision Medicine World Conference 2025
February 3rd 2025

Exploring Precision Medicine and PGx: Sara Rogers, PharmD, Previews Precision Medicine World Conference 2025

HER2-ultralow now refers to patients who have low levels of HER2 expression, is lower than the existing HER2-low category. | Image Credit: Saiful52 | stock.adobe.com
February 1st 2025

FDA Approves Diagnostic Label Expansion for HR+, HER2–Ultra-Low Metastatic Breast Cancer

Ashley Gallagher, Editor